Organon & Co. — Director's Dealing 2022

May 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2022-05-04

Reporting Person: WALSH MATTHEW M (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-04	Common Stock	M	8310	—	Acquired	23000	Direct
2022-05-04	Common Stock	F	2847	$32.44	Disposed	20153	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-04	Restricted Stock Units	$	M	8310	Disposed	2024-05-04	Common Stock (8310)	Direct

Footnotes

F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.

F2: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024.